| Autor: |
Warren, R.B., Reich, K., Langley, R.G., Strober, B., Gladman, D., Deodhar, A., Bachhuber, T., Bao, W., Altemeyer, E., Hussain, S., Safi, J. |
| Předmět: |
|
| Zdroj: |
British Journal of Dermatology; Nov2018, Vol. 179 Issue 5, p1205-1207, 3p |
| Abstrakt: |
The article focuses on the impact of secukinumab in pregnancy with outcomes psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database and adverse effect on health-related quality of life during pregnancy. It mentions secukinumab is a fully human monoclonal antibody that selectively targets ilnterleukin-17A and sustained efficacy in the treatment of moderate-to-severe psoriasis. It also mentions secukinumab on pregnancy outcomes or spermatogenesis. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text